Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A shot at AIDS.

Wayne C Koff1

  • 1IAVI Chief Scientific Officer.

Current Opinion in Biotechnology
|May 7, 2016
PubMed
Summary
This summary is machine-generated.

Developing an effective HIV vaccine remains a challenge, despite advances in treatments and prevention. Research focuses on eliciting broadly neutralizing antibodies and cellular immunity against diverse HIV variants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerating development of vaccines for prevention and control of Alzheimer's disease.

Vaccine·2025
Same author

AI and the future of vaccine development.

Vaccine·2024
Same author

Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development.

Journal of molecular biology·2023
Same author

Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response.

Frontiers in immunology·2021
Same author

A universal coronavirus vaccine.

Science (New York, N.Y.)·2021
Same author

Development and deployment of COVID-19 vaccines for those most vulnerable.

Science translational medicine·2021
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Significant progress has been made in HIV treatments and prevention strategies over the past 35 years.
  • However, an effective vaccine to prevent HIV infection remains elusive.
  • Licensed vaccines typically rely on antibody induction for protection.

Purpose of the Study:

  • To summarize recent advances in HIV vaccine development.
  • To highlight the challenges posed by HIV diversity.
  • To discuss strategies for developing a broadly protective HIV vaccine.

Main Methods:

  • Identification and characterization of broadly neutralizing antibodies.
  • Design of vaccine candidates targeting cellular immunity.
  • Analysis of results from recent clinical trials.

Related Experiment Videos

Main Results:

  • Progress in identifying broadly neutralizing antibodies offers new avenues for vaccine design.
  • Advances in stimulating cellular immunity are being explored.
  • Recent clinical trial data are informing future vaccine development efforts.

Conclusions:

  • Developing an HIV vaccine requires overcoming the challenge of viral diversity.
  • Strategies focusing on broadly neutralizing antibodies and cellular immunity are crucial.
  • Continued research and clinical trials are essential to achieve an effective HIV vaccine.